Foscenvivint

DRUG2 trials

Sponsors

Kiminori Kimura, MD

Conditions

Liver Cirrhosis

Phase 2

A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)

CompletedNCT06144086

Kiminori Kimura, MDLiver Cirrhosis

Start: 2024-05-08End: 2025-03-27Updated: 2026-05-01

A Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia

RecruitingNCT07681089

Kiminori Kimura, MDLiver Cirrhosis

Start: 2026-09-01End: 2028-03-31Target: 4Updated: 2026-08-05